Quick Answer (for busy buyers)
Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.
- The best approach is a water-free anhydrous formula based on light, high-penetration esters and non-greasy oils.
- Key ingredients include caprylic/capric triglyceride, squalane, or jojoba oil, which mimic skin lipids for quick absorption.
- Silicones like cyclopentasiloxane can be added to reduce tackiness and improve spreadability, but their percentage must be balanced to avoid a heavy residue.
- Formulation must avoid heavy mineral oil fractions and use refined, cosmetic-grade actives to meet US FDA and pediatric safety standards for leave-on products.
- For production, MOQ typically starts at 5,000 units per SKU to justify batch setup and ingredient sourcing.
- Sampling timeline is 4-6 weeks after ingredient approval, involving 2-3 sample rounds to fine-tune absorption rate and sensory profile.
- Testing is critical: we conduct in-vitro skin irritation tests, stability testing for 3 months at various temperatures, and microbial challenge tests to ensure safety over shelf life.
- Packaging often uses PET or HDPE bottles with fine-mist pumps or flip-top caps to control application and minimize leakage; we run compatibility tests to check for oil interaction with plasticizers.
- Lead time from approved sample to bulk production is 8-10 weeks, factoring in raw material lead times and QA checks like viscosity and fill weight.
- We support full documentation for US compliance, including ingredient declarations, PIFs, and batch records, but cannot guarantee regulatory approval as it depends on final formula submission.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
